ArticleEmerging infectious diseases2008
Ceftriaxone-resistant salmonella enterica serotype Newport, France.
Article in Emerging infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.
- Worldwide Epidemiology ofApplied and environmental microbiology · 2019Pooled it
- Investigation of prevalence and antimicrobial resistance of Salmonella in pet dogs and cats in Turkey.Veterinary medicine and science · 2024Article
- Characterisation and mobilisation of IncA/C plasmid-mediated antibiotic resistance in Edwardsiella ictaluri.Journal of global antimicrobial resistance · 2023Article
- Bacterial Infection in the Sickle Cell Population: Development and Enabling Factors.Microorganisms · 2023Review
- High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.BMC infectious diseases · 2021Article
- Emerging colistin resistance inEmerging microbes & infections · 2020Article
- Antibiotic-Resistant Extended Spectrum ß-Lactamase- and Plasmid-Mediated AmpC-Producing Enterobacteriaceae Isolated from Retail Food Products and the Pearl River in Guangzhou, China.Frontiers in microbiology · 2017Article
- IncA/C plasmid-mediated spread of CMY-2 in multidrug-resistant Escherichia coli from food animals in China.PloS one · 2014Article
- Antibiotic resistance pattern among the Salmonella isolated from human, animal and meat in India.Tropical animal health and production · 2012Article
- Selection pressure required for long-term persistence of blaCMY-2-positive IncA/C plasmids.Applied and environmental microbiology · 2011Article
- Evolution and population structure of Salmonella enterica serovar Newport.Journal of bacteriology · 2010Article
- Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.Antimicrobial agents and chemotherapy · 2010Article
- Article
- Ceftazidime-resistant Salmonella enterica, Morocco.Emerging infectious diseases · 2009Article
- Resistance plasmid families in Enterobacteriaceae.Antimicrobial agents and chemotherapy · 2009Review
- IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.Antimicrobial agents and chemotherapy · 2009Article
- AmpC beta-lactamases.Clinical microbiology reviews · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 7 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 beta-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000-2005. Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.